NLRP3/IL-1 pathway was reduced by semaglutide and dapagliflozin in association therapy under exposure to anthracyclines in hyperglycemic conditions
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
3 More presentations in this session
Associate Professor J. Strom (Boston, US)
Associate Professor B. Polegato (Botucatu, BR)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
You may be interested in
Congress Presentation
Congress Session
